A majority of cardiovascular implantable electronic devices (CIEDs) in the U.S. are still MR-nonconditional, but a pair of neurologists believe hospitals need to assess their institutional policy to ensure patients have access to MRIs when needed.
University of Kansas (KU) Cancer Center researchers have launched a clinical trial eliminating radiation therapy from treatment for the invasive type of breast cancer that affects nearly a fifth of all breast cancer patients, according to a KU news release.
The American College of Radiology (ACR) submitted written comments to CMS, taking issue with its proposed Inpatient Prospective Payment System (IPPS) rule for 2019.
When researchers bought more than 200 types of tea, chocolate, herbs and other items they weren’t planning meals for the week. Instead, the team was searching for a contrast agent for imaging patients with swallowing disorders—they landed on barley.
Self-identified radiologists tallied more than $16 million in political contributions between 2003 and 2016, a Journal of the American College of Radiology study found. The majority of those dollars went to the Radiology Political Action Committee (RADPAC).
Konica Minolta Healthcare Americas, Inc., announces the introduction of the SONIMAGE® MX1 portable ultrasound system, optimized for musculoskeletal (MSK) and orthopedic practices, interventional guidance and outpatient centers.
A $2 million investment for a third MRI scanner at the University of Minnesota’s Clinics and Surgery Center aims to cut into the typical two- or three-week wait time for patients.
Adding fluorine-18 (18F)-fluciclovine PET/CT to the diagnostic treatment plan of patients with biochemical recurrence of prostate cancer can identify previously undetected lesions and alter treatment management for patients with the disease.
A large study utilizing automated mammography revealed a higher cancer rate in women with dense breast tissue compared to those with less-dense breasts, according to recent research published in Radiology
Studies examining breast cancer risk and treatment outcomes are not adequately incorporating race and socioeconomic factors such as education level and economic status, according to a Johns Hopkins release.
